Avicanna Inc. (AVCN.TO)

CAD 0.34

(1.49%)

Net Income Summary of Avicanna Inc.

  • Avicanna Inc.'s latest annual net income in 2023 was -8.74 Million CAD , up 54.21% from previous year.
  • Avicanna Inc.'s latest quarterly net income in 2024 Q1 was -788.68 Thousand CAD , up 69.4% from previous quarter.
  • Avicanna Inc. reported an annual net income of -17.21 Million CAD in 2022, down -2.65% from previous year.
  • Avicanna Inc. reported an annual net income of -16.77 Million CAD in 2021, up 48.95% from previous year.
  • Avicanna Inc. reported a quarterly net income of -1.75 Million CAD for 2024 Q2, down -146.64% from previous quarter.
  • Avicanna Inc. reported a quarterly net income of -2.57 Million CAD for 2023 Q4, down -80.96% from previous quarter.

Annual Net Income Chart of Avicanna Inc. (2023 - 2016)

Historical Annual Net Income of Avicanna Inc. (2023 - 2016)

Year Net Income Net Income Growth
2023 -8.74 Million CAD 54.21%
2022 -17.21 Million CAD -2.65%
2021 -16.77 Million CAD 48.95%
2020 -32.86 Million CAD -47.94%
2019 -22.21 Million CAD -212.9%
2018 -7.09 Million CAD -173.09%
2017 -2.59 Million CAD -8614.03%
2016 -29.83 Thousand CAD 0.0%

Peer Net Income Comparison of Avicanna Inc.

Name Net Income Net Income Difference
Aurora Cannabis Inc. -69.32 Million CAD 87.389%
Avant Brands Inc. -5.07 Million CAD -72.446%
Cardiol Therapeutics Inc. -28.12 Million CAD 68.917%
Crescita Therapeutics Inc. -1.98 Million CAD -340.232%
Knight Therapeutics Inc. -16.83 Million CAD 48.067%
MediPharm Labs Corp. -13.08 Million CAD 33.173%
OrganiGram Holdings Inc. -229.47 Million CAD 96.19%
Canopy Growth Corporation -657.26 Million CAD 98.67%
Willow Biosciences Inc. -13.02 Million CAD 32.896%
Auxly Cannabis Group Inc. -44.51 Million CAD 80.358%